Cross Country Healthcare, Inc. (NASDAQ:CCRN - Get Free Report) has earned a consensus recommendation of "Hold" from the five brokerages that are covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold recommendation. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $18.54.
A number of analysts have recently commented on the company. StockNews.com assumed coverage on Cross Country Healthcare in a research note on Saturday. They issued a "hold" rating on the stock. Truist Financial upped their price target on shares of Cross Country Healthcare from $15.00 to $18.61 and gave the stock a "hold" rating in a research report on Thursday, December 5th. Barrington Research reaffirmed a "market perform" rating on shares of Cross Country Healthcare in a research note on Tuesday, December 10th. JMP Securities restated a "market perform" rating on shares of Cross Country Healthcare in a research report on Thursday. Finally, William Blair lowered shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 4th.
Get Our Latest Research Report on CCRN
Institutional Investors Weigh In On Cross Country Healthcare
Institutional investors and hedge funds have recently modified their holdings of the company. Alpine Associates Management Inc. purchased a new stake in shares of Cross Country Healthcare during the fourth quarter worth $10,552,000. Jacobs Levy Equity Management Inc. acquired a new position in Cross Country Healthcare in the third quarter valued at $7,350,000. Royce & Associates LP grew its stake in Cross Country Healthcare by 51.4% during the 3rd quarter. Royce & Associates LP now owns 1,132,566 shares of the business services provider's stock worth $15,222,000 after buying an additional 384,374 shares during the last quarter. Zweig DiMenna Associates LLC acquired a new position in shares of Cross Country Healthcare in the 4th quarter valued at $6,841,000. Finally, ABC Arbitrage SA purchased a new stake in shares of Cross Country Healthcare in the fourth quarter valued at about $3,038,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Cross Country Healthcare Stock Down 0.1 %
Shares of Cross Country Healthcare stock traded down $0.02 on Thursday, reaching $18.18. 347,210 shares of the stock were exchanged, compared to its average volume of 371,206. Cross Country Healthcare has a twelve month low of $9.58 and a twelve month high of $21.41. The business has a 50 day moving average price of $17.85 and a two-hundred day moving average price of $14.90. The firm has a market capitalization of $596.59 million, a price-to-earnings ratio of -363.53, a PEG ratio of 3.35 and a beta of 0.44.
About Cross Country Healthcare
(
Get Free ReportCross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Further Reading

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.